1368 related articles for article (PubMed ID: 32230811)
1. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811
[TBL] [Abstract][Full Text] [Related]
2. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Di Matteo V; Esposito E
Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802
[TBL] [Abstract][Full Text] [Related]
4. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
[TBL] [Abstract][Full Text] [Related]
5. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
6. Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses.
Gunnarsson LG; Bodin L
Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30691095
[No Abstract] [Full Text] [Related]
7. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin E on neurodegenerative diseases: an update.
Icer MA; Arslan N; Gezmen-Karadag M
Acta Neurobiol Exp (Wars); 2021; 81(1):21-33. PubMed ID: 33949169
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.
Garofalo M; Pandini C; Bordoni M; Pansarasa O; Rey F; Costa A; Minafra B; Diamanti L; Zucca S; Carelli S; Cereda C; Gagliardi S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327559
[TBL] [Abstract][Full Text] [Related]
11. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Gaggelli E; Kozlowski H; Valensin D; Valensin G
Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
[No Abstract] [Full Text] [Related]
12. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
13. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
14. Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.
Sun J; Ludvigsson JF; Ingre C; Piehl F; Wirdefeldt K; Zagai U; Ye W; Fang F
PLoS Med; 2022 Sep; 19(9):e1004092. PubMed ID: 36107840
[TBL] [Abstract][Full Text] [Related]
15. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
16. The Role of Bioenergetics in Neurodegeneration.
Strope TA; Birky CJ; Wilkins HM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
[TBL] [Abstract][Full Text] [Related]
17. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways.
Majd S; Power JH; Grantham HJ
BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115
[TBL] [Abstract][Full Text] [Related]
18. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
19. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
[TBL] [Abstract][Full Text] [Related]
20. 4-hydroxynonenal and neurodegenerative diseases.
Zarkovic K
Mol Aspects Med; 2003; 24(4-5):293-303. PubMed ID: 12893007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
